SIGNALLING PATHWAYS AND MOLECULAR TARGETS FOR SKIN CANCER: INVOLVEMENT OF CDK2 INHIBITION. Nirma University Journal of Pharmaceutical Sciences, [S. l.], v. 5, n. 1, p. 41–58, 2018. DOI: 10.5281/. Disponível em: https://journals.nirmauni.ac.in/index.php/pharmacy/article/view/455. Acesso em: 3 apr. 2025.